Severely recalcitrant pyoderma gangrenosum successfully treated with ustekinumab - 12/10/12
Doi : 10.1016/j.jaad.2012.04.045
Ari M. Goldminz, BA ⁎ 
, Nina C. Botto, MD, Alice B. Gottlieb, MD, PhD
, Nina C. Botto, MD, Alice B. Gottlieb, MD, PhD Department of Dermatology, Tufts Medical Center, Boston, Massachusetts
Correspondence to: Ari M. Goldminz, BA, Tufts Medical Center, 800 Washington St, Box 114, Boston, MA 02111| Funding sources: None. |
|
| Disclosure: Dr Gottlieb is an investigator with the following: Abbott Laboratories, Amgen Inc, Celgene Corp, Immune Control, Janssen Biotech Inc, Novartis Pharmaceuticals Corp, Novo Nordisk A/S, Pfizer Inc, and UCB. She currently has consulting/advisory board agreements with the following: Abbott Laboratories, Actelion, Amgen Inc, Astellas Pharma US Inc, Beiersdorf Inc, Bristol Myers Squibb Co, Canfite, Celgene Corp, Dermipsor Ltd, Incyte Corp, Janssen Biotech Inc, Lilly ICOS LLC, Merk & Co Inc, Novartis Pharmaceuticals Corp, Novo Nordisk A/S, Pfizer Inc, TEVA, and UCB. She has research/educational grants with the following: Abbott Laboratories, Amgen Inc, Celgene Corp, Immune Control, Novartis Pharmaceuticals Corp, Novo Nordisk A/S, Pfizer Inc, and UCB. Mr Goldminz and Dr Botto have no conflicts of interest to declare. |
© 2012
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 67 - N° 5
P. e237-e238 - novembre 2012 Retour au numéro
Article précédent
- Hemophagocytic syndrome as the presenting manifestation of bacillary angiomatosis in a renal transplant recipient
- Marie Grabas, Laure Darrieux, Jérôme Potier, Gilles Safa
- Intravascular B-cell lymphoma presenting as retiform purpura
- Lacey Kruse, Lucinda Buescher, Elizabeth Nietert
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?